Lyc-O-Fem should answer concerns about fast-metabolizing genistein.
LycoRed (Beer Sheva, Israel) is now supplying the dietary supplement industry with Lyc-O-Fem, a slow-release bone health formula centered on genistein, a phytoestrogen associated with bone health improvements in clinical studies. The formula combines genistein from Japanese pagoda tree (Sophora japonica), tomato lycopene, and vitamin D3.
The company says it launched the slow-release format because of growing concern that genistein is metabolized too quickly, often requiring a twice-daily administration of the supplement. “The slow-release technology in LycoRed’s preparation provides a continuous exposure, allowing once-a-day supplementation,” said the company in a recent press release.
Lyc-O-Fem can also serve as the basis for menopausal relief products, since genistein has demonstrated clinical promise in this area as well.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Glanbia Nutritionals announces launch of high potency collagen tripeptide ingredient
June 4th 2024According to the company, Collamet is absorbed four times faster and has 10 times the efficacy of traditional collagen peptides. The ingredient will initially be offered in the North American market.